Brian P. Rubin

30.9k total citations · 6 hit papers
275 papers, 19.2k citations indexed

About

Brian P. Rubin is a scholar working on Pulmonary and Respiratory Medicine, Rheumatology and Oncology. According to data from OpenAlex, Brian P. Rubin has authored 275 papers receiving a total of 19.2k indexed citations (citations by other indexed papers that have themselves been cited), including 168 papers in Pulmonary and Respiratory Medicine, 80 papers in Rheumatology and 75 papers in Oncology. Recurrent topics in Brian P. Rubin's work include Sarcoma Diagnosis and Treatment (153 papers), Gastrointestinal Tumor Research and Treatment (54 papers) and Soft tissue tumor case studies (41 papers). Brian P. Rubin is often cited by papers focused on Sarcoma Diagnosis and Treatment (153 papers), Gastrointestinal Tumor Research and Treatment (54 papers) and Soft tissue tumor case studies (41 papers). Brian P. Rubin collaborates with scholars based in United States, Canada and Japan. Brian P. Rubin's co-authors include Christopher L. Corless, Christopher D.�M. Fletcher, Michael C. Heinrich, John R. Goldblum, B. Jack Longley, Sharon W. Weiss, Jonathan A. Fletcher, Markku Miettinen, Jerzy Lasota and Helen Remotti and has published in prestigious journals such as Cell, Proceedings of the National Academy of Sciences and The Lancet.

In The Last Decade

Brian P. Rubin

270 papers receiving 18.7k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Diagnosis of gastrointestinal stromal tumors: A consensus approach

2002 2.5k citations Christopher D.�M. Fletcher, Christopher L. Corless et al. profile →
Gastrointestinal stromal tumour

2007 813 citations Brian P. Rubin, Michael C. Heinrich et al. profile →
KIT activation is a ubiquitous feature of gastrointestinal stromal tumors.

2001 789 citations Brian P. Rubin, Anette Duensing et al. profile →
KIT Extracellular and Kinase Domain Mutations in Gastrointestinal Stromal Tumors

2000 538 citations Brian P. Rubin, Christopher D.�M. Fletcher et al. American Journal Of Pathology profile →
TPM3-ALK and TPM4-ALK Oncogenes in Inflammatory Myofibroblastic Tumors

2000 515 citations Brian P. Rubin, Paola Dal Cin et al. American Journal Of Pathology profile →
The Novel Marker, DOG1, Is Expressed Ubiquitously in Gastrointestinal Stromal Tumors Irrespective of KIT or PDGFRA Mutation Status

2004 487 citations Robert B. West, Christopher L. Corless et al. American Journal Of Pathology profile →

Peers

Countries citing papers authored by Brian P. Rubin

Since Specialization

Citations

This map shows the geographic impact of Brian P. Rubin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Brian P. Rubin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Brian P. Rubin more than expected).

Fields of papers citing papers by Brian P. Rubin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Brian P. Rubin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Brian P. Rubin. The network helps show where Brian P. Rubin may publish in the future.

Co-authorship network of co-authors of Brian P. Rubin

This figure shows the co-authorship network connecting the top 25 collaborators of Brian P. Rubin. A scholar is included among the top collaborators of Brian P. Rubin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Brian P. Rubin. Brian P. Rubin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Nuclear DUX4 immunohistochemistry is a highly sensitive and specific marker for the presence of CIC::DUX4 fusion in CIC‐rearranged sarcomas: a study of 48 molecularly confirmed cases 2024 ·Histopathology ·(unknown), (unknown), (unknown), (unknown), Brian P. Rubin, Scott E. Kilpatrick, John R. Goldblum, (unknown), Steven D. Billings, Michal Michal, Marián Švajdler, Zdeněk Kinkor, Michael Michal, Josephine K. Dermawan	4
2	Loss of CDKN2A Cooperates with WWTR1(TAZ)–CAMTA1 Gene Fusion to Promote Tumor Progression in Epithelioid Hemangioendothelioma 2023 ·Clinical Cancer Research ·Caleb N. Seavey, (unknown), Shuo Li, (unknown), Ajaybabu V. Pobbati, (unknown), (unknown), (unknown), John M. Lamar, Brian P. Rubin	16
3	Superficial low‐grade fibromyxoid sarcoma 2022 ·Journal of Cutaneous Pathology ·Shira Ronen, Jennifer S. Ko, Brian P. Rubin, Scott E. Kilpatrick, Wei‐Lien Wang, Alexander J. Lazar, John R. Goldblum, Steven D. Billings	6
4	Whole-genome characterization of myoepithelial carcinomas of the soft tissue 2022 ·Molecular Case Studies ·Joanna Cyrta, Joel Rosiene, Rohan Bareja, Sarah Kudman, Wael Al Zoughbi, Samaneh Motanagh, David Wilkes, Kenneth Eng, Tuo Zhang, (unknown), Susan Mathew, Mark A. Rubin, Andrea Sboner, Olivier Elemento, Brian P. Rubin, Marcin Imieliński, Juan Miguel Mosquera	2
5	The capillary lobule variant of radiation‐associated angiosarcoma in the setting of breast cancer: A diagnostic pitfall 2022 ·Journal of Cutaneous Pathology ·(unknown), Karen Fritchie, Anthony P. Fernandez, Jennifer S. Ko, Wilma F. Bergfeld, Brian P. Rubin, Steven D. Billings	2
6	WWTR1(TAZ)-CAMTA1 gene fusion is sufficient to dysregulate YAP/TAZ signaling and drive epithelioid hemangioendothelioma tumorigenesis 2021 ·Genes & Development ·Caleb N. Seavey, Ajaybabu V. Pobbati, (unknown), Shuang Ma, Jordan Reynolds, (unknown), John M. Lamar, Brian P. Rubin	45
7	Superficial ALK-rearranged myxoid spindle cell neoplasm: a cutaneous soft tissue tumor with distinctive morphology and immunophenotypic profile 2021 ·Modern Pathology ·Josephine K. Dermawan, Elizabeth M. Azzato, John R. Goldblum, Brian P. Rubin, Steven D. Billings, Jennifer S. Ko	44
8	Superficial sarcomas with CIC rearrangement are aggressive neoplasms: A series of eight cases 2020 ·Journal of Cutaneous Pathology ·Jennifer S. Ko, Zlatko Marušić, Elizabeth M. Azzato, Daniel H. Farkas, John Van Arnam, Sven Seiwerth, Karen Fritchie, Rajiv M. Patel, Brian P. Rubin, Steven D. Billings	25
9	EWSR1-SMAD3–rearranged Fibroblastic Tumor 2018 ·The American Journal of Surgical Pathology ·Michael Michal, R. Stephen Berry, Brian P. Rubin, Scott E. Kilpatrick, Abbas Agaimy, Dmitry V. Kazakov, Petr Šteiner, Nikola Ptáková, Petr Martínek, Ladislav Hadravský, Květoslava Michalová, (unknown), Michal Michal	34
10	Olaratumab Exerts Antitumor Activity in Preclinical Models of Pediatric Bone and Soft Tissue Tumors through Inhibition of Platelet-Derived Growth Factor Receptor α 2017 ·Clinical Cancer Research ·Caitlin D. Lowery, Wayne Blosser, Michele Dowless, (unknown), Jennifer R. Stephens, Huiling Li, David Surguladze, Nick Loizos, Debra Luffer‐Atlas, Gerard J. Oakley, Qianxu Guo, Seema Iyer, Brian P. Rubin, Louis F. Stancato	26
11	NSD3–NUT Fusion Oncoprotein in NUT Midline Carcinoma: Implications for a Novel Oncogenic Mechanism 2014 ·Cancer Discovery ·Christopher A. French, Shaila Rahman, Erica M. Walsh, Simone Kühnle, Adlai R. Grayson, Madeleine E. Lemieux, Noam Grunfeld, Brian P. Rubin, Cristina R. Antonescu, Songlin Zhang, Rajkumar Venkatramani, Paola Dal Cin, Peter M. Howley	186
12	Crosstalk between KIT and FGFR3 Promotes Gastrointestinal Stromal Tumor Cell Growth and Drug Resistance 2014 ·Cancer Research ·Nathalie Javidi‐Sharifi, Elie Traer, Jacqueline Martinez, Anu Gupta, (unknown), Jennifer Dunlap, Michael C. Heinrich, Christopher L. Corless, Brian P. Rubin, Brian Druker, Jeffrey Tyner	86
13	IL-4R Drives Dedifferentiation, Mitogenesis, and Metastasis in Rhabdomyosarcoma 2011 ·Clinical Cancer Research ·Tohru Hosoyama, Mohammed Aslam, Jinu Abraham, Suresh I. Prajapati, Koichi Nishijo, Joel Michalek, Lee Ann Zarzabal, (unknown), Denis C. Guttridge, Brian P. Rubin, Charles Keller	52
14	Evasion Mechanisms to Igf1r Inhibition in Rhabdomyosarcoma 2011 ·Molecular Cancer Therapeutics ·Jinu Abraham, Suresh I. Prajapati, Koichi Nishijo, Beverly S. Schaffer, Eri Taniguchi, (unknown), Amanda T. McCleish, (unknown), (unknown), Argiris Efstratiadis, Robin D. LeGallo, (unknown), Brian P. Rubin, Suman Malempati, Charles Keller	44
15	Immune Competency of a Hairless Mouse Strain for Improved Preclinical Studies in Genetically Engineered Mice 2010 ·Molecular Cancer Therapeutics ·Beverly S. Schaffer, Mitchell H. Grayson, (unknown), (unknown), Amanda T. McCleish, Suresh I. Prajapati, (unknown), (unknown), Inkyung Jung, Tohru Hosoyama, (unknown), Martha A. Hanes, Brian P. Rubin, Joel Michalek, Charles B. Clifford, Anthony J. Infante, Charles Keller	37
16	Credentialing a Preclinical Mouse Model of Alveolar Rhabdomyosarcoma 2009 ·Cancer Research ·Koichi Nishijo, Qingrong Chen, Lei Zhang, Amanda T. McCleish, (unknown), Min Jung Cho, Suresh I. Prajapati, Jonathan Gelfond, Gary B. Chisholm, Joel Michalek, Bruce J. Aronow, Frederic G. Barr, R. Lor Randall, Marc Ladanyi, Stephen J. Qualman, Brian P. Rubin, Robin D. LeGallo, Chiayeng Wang, Javed Khan, Charles Keller	66
17	Proapoptotic Activity of Bortezomib in Gastrointestinal Stromal Tumor Cells 2009 ·Cancer Research ·Sebastian Bauer, Joshua A. Parry, Thomas Mühlenberg, Matthew F. Brown, Danushka S. Seneviratne, Payel Chatterjee, Anna Chin, Brian P. Rubin, (unknown), Jonathan A. Fletcher, Stefan Duensing, Anette Duensing	34
18	Genome-wide transcriptome analysis of nerve sheath tumors 2006 ·Cancer Research ·Subbaya Subramanian, Robert B. West, Torsten O. Nielsen, Brian P. Rubin, Erinn Downs‐Kelly, John R. Goldblum, Shirley Zhu, Kelli Montgomery, Pancras C.W. Hogendoorn, Christopher L. Corless, André M. Oliveira, Christopher D.�M. Fletcher, Matt van de Rijn	1
19	The Novel Marker, DOG1, Is Expressed Ubiquitously in Gastrointestinal Stromal Tumors Irrespective of KIT or PDGFRA Mutation Status breakdown → 2004 ·American Journal Of Pathology ·Robert B. West, Christopher L. Corless, Xin Chen, Brian P. Rubin, Subbaya Subramanian, Kelli Montgomery, Shirley Zhu, Catherine A. Ball, Torsten O. Nielsen, Rajiv M. Patel, John R. Goldblum, Patrick O. Brown, Michael C. Heinrich, Matt van de Rijn	487
20	Gene Expression Patterns and Gene Copy Number Changes in Dermatofibrosarcoma Protuberans 2003 ·American Journal Of Pathology ·Sabine C. Linn, Robert B. West, Jonathan R. Pollack, Shirley Zhu, Tina Hernandez‐Boussard, Torsten O. Nielsen, Brian P. Rubin, Rajiv M. Patel, John R. Goldblum, David Siegmund, David Botstein, Patrick O. Brown, C. Blake Gilks, Matt van de Rijn	107

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact